human thioredoxin; X-ray crystal structure; mitochondria; oxidized state; reduced state
Abstract :
[en] Mammalian thioredoxin 2 is a mitochondrial isoform of highly evolutionary conserved thioredoxins.
Thioredoxins are small ubiquitous protein–disulfide oxidoreductases implicated in a large variety of
biological functions. In mammals, thioredoxin 2 is encoded by a nuclear gene and is targeted to
mitochondria by a N-terminal mitochondrial presequence. Recently, mitochondrial thioredoxin 2 was
shown to interact with components of the mitochondrial respiratory chain and to play a role in the
control of mitochondrial membrane potential, regulating mitochondrial apoptosis signaling pathway.
Here we report the first crystal structures of a mammalian mitochondrial thioredoxin 2. Crystal forms of
reduced and oxidized human thioredoxin 2 are described at 2.0 and 1.8A ˚ resolution. Though the folding
is rather similar to that of human cytosolic/nuclear thioredoxin 1, important differences are observed
during the transition between the oxidized and the reduced states of human thioredoxin 2, compared
with human thioredoxin 1. In spite of the absence of the Cys residue implicated in dimer formation in
human thioredoxin 1, dimerization still occurs in the crystal structure of human thioredoxin 2, mainly
mediated by hydrophobic contacts, and the dimers are associated to form two-dimensional polymers.
Interestingly, the structure of human thioredoxin 2 reveals possible interaction domains with human
peroxiredoxin 5, a substrate protein of human thioredoxin 2 in mitochondria.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Smeets, Aude; Université Catholique de Louvain - UCL > Département de Chimie > Unité de Chimie Structurale (CSTR)
Evrard, Christine ; Université Catholique de Louvain - UCL > Département de Chimie > Unité de Chimie Structurale (CSTR)
Landtmeters, Marie; Université Catholique de Louvain - UCL > Institut des sciences de la vie - ISV
Marchand, Cécile; Université Catholique de Louvain - UCL > Institut des sciences de la vie - ISV
Knoops, Bernard; Université Catholique de Louvain - UCL > Institut des sciences de la vie - ISV
Declercq, Jean-Paul; Université Catholique de Louvain - UCL > Département de Chimie > Unité de Chimie Structurale (CSTR)
Language :
English
Title :
Crystal structures of oxidized and reduced forms of human mitochondrial thioredoxin 2
Publication date :
2005
Journal title :
Protein Science: A Publication of the Protein Society
ISSN :
0961-8368
eISSN :
1469-896X
Publisher :
Cold Spring Harbor Laboratory Press, Woodbury, United States - New York
Arner, E.S. and Holmgren, A. 2000. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267: 6102-6109.
Capitani, G., Marković-Housley, Z., DelVal, G., Morris, M., Jansonius, J.N., and Schürmann, P. 2000. Crystal structures of two functionally different thioredoxins in spinach chloroplasts. J. Mol. Biol. 302: 135-154.
Chen, Y., Cai, J., Murphy, T.J., and Jones, D.J. 2002. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277: 33242-33248.
Choi, J., Choi, S., Choi, J., Cha, M.K., Kim, I.H., and Shin, W. 2003. Crystal structure of Escherichia coli thiol peroxidase in the oxidized state. Insight into intramolecular disulfide formation and substrate binding in atypical 2-cys peroxiredoxins. J. Biol. Chem. 278: 49478-49486.
Collaborative Computational Project, Number 4. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D Biol. Crystal logr. 50: 760-763.
Damdimopoulos, A.E., Miranda-Vizuete, A., Pelto-Huikko, M., Gustafsson, J.-A., and Spyrou, G. 2002. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J. Biol. Chem. 277: 33249-33257.
Declercq, J.-P., Evrard, C., Clippe, A., Vander Stricht, D., Bernard, A., and Knoops, B. 2001. Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 Å resolution. J. Mol. Biol. 311: 751-759.
Evrard, C., Capron, A., Marchand, C., Clippe, A., Wattiez, R., Soumillion, P., Knoops, B., and Declercq, J.-P. 2004. Crystal structure of a dimeric oxidized form of human peroxiredoxin 5. J. Mol. Biol. 337: 1079-1090.
Harris, M. and Jones, T.A. 2001. Molray - A web interface between O and the POV-Ray ray tracer. Acta Crystallogr. D Biol. Crystallogr. 57: 1201-1203.
Hofmann, B., Hecht, H.-J., and Flohé, L. 2002. Peroxiredoxins. Biol. Chem. 383: 347-364.
Holmgren, A. 1985. Thioredoxin. Annu. Rev. Biochem. 54: 237-271.
Holmgren, A. and Bjornstedt, M. 1995. Thioredoxin and thioredoxin reductase. Methods Enzymol. 252: 199-208.
Jeng, M.-F., Campbell, A.P., Begley, T., Holmgren, A., Case, D.A., Wright, P.E., and Dyson, H.J. 1994. High-resolution solution structures of oxidized and reduced Escherichia coli thioredoxin. Structure 2: 853-868.
Jimenez, A., Zu, W., Rawe, V.Y., Pelto-Huikko, M., Flickinger, C.J., Sutovsky, P., Gustafsson, J.-A., Oko, R., and Miranda-Vizuete, A. 2004. Spermatocyte/spermatid-specific thioredoxin-3, a novel Golgi apparatus-associated thioredoxin, is a specific marker of aberrant spermatogenesis. J. Biol. Chem. 279: 34971-34982.
Jones, T.A., Zou, J.-Y., Cowan, S.W., and Kjeldgaard, M. 1991. Improved methods for building protein models in electron-density maps and the location of errors in these models. Acta Crystallogr. A 47: 110-119.
Kabsch, W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 26: 795-800.
Kallis, G.-B. and Holmgren, A. 1980. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. J. Biol. Chem. 255: 10261-10265.
Katti, S.K., LeMaster, D.M., and Eklund, H. 1990. Crystal structure of thioredoxin from Escherichia coli at 1.68 Å resolution. J. Mol. Biol. 212: 167-184.
Kerr, K.A. and Ashmore, J.P. 1975. A neutron diffraction study of Lcysteine. Acta Crystallogr. B 31: 2022-2026.
Kim, S.J., Woo, J.R., Hwang, Y.S., Jeong, D.G., Shin, D.H., Kim, K. and Ryu, S.E. 2003. The tetrameric structure of Haemophilus influenza hybrid Prx5 reveals interactions between electron donor and acceptor proteins. J. Biol. Chem. 278: 10790-10798.
Kleywegt, G.J. and Jones, T.A. 1997. Detecting folding motifs and similarities in protein structures. Methods Enzymol. 277: 525-545.
Knoops, B., Clippe, A., Bogard, C., Arsalane, K., Wattiez, R., Hermans, C., Duconseille, E., Falmagne, P., and Bernard, A. 1999. Clon- ing and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J. Biol. Chem. 274: 30451-30458.
Kortemme, T. and Creighton, T.E. 1995. Ionisation of cysteine residues at the termini of model α-helical peptides. Relevance to unusual thiol pKa values in proteins of the thioredoxin family. J. Mol. Biol. 253: 799-812.
Kraulis, P.J. 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24: 946-950.
Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26: 283-291.
Laurent, T.C., Moore, E.C., and Reichard, P. 1964. Enzymatic synthesis of deoxyribonucleotides. J. Biol. Chem. 239: 3436-3444.
Martin, J.F. 1995. Thioredoxin - A fold for all reasons. Structure 3: 245-250.
Miranda-Vizuete, A., Damdimopoulos, A.E., and Spyrou, G. 2000. The mitochondrial thioredoxin system. Antiox. Redox Signal. 2: 801-810.
Murshudov, G.N., Vagin, A.A. and Dodson, E.J. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53: 240-255.
Nicholls, A., Bharadway, R., and Honig, B. 1993. GRASP: Graphical representation and analysis of surface properties. Biophys. J. 64: 166-170.
Nonn, L., Williams, R.R., Erickson, R.P., and Powis, G. 2003. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice.Mol. Cell. Biol. 23: 916-922.
Powis, G., Mustacich, D., and Coon, A. 2000. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29: 312-322.
Powis, G. and Montfort, W.R. 2001. Properties and biological activities of thioredoxins. Annu. Rev. Biophys. Biomol. Struct. 30: 421-455.
Qin, J., Clore, G.M., and Gronenborn, A.M. 1994. The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin. Structure 2: 503-522.
Read, R.J. 2001. Pushing the boundaries of molecular replacement with maximum-likelihood. Acta Crystallogr.DBiol. Crystallogr. 57: 1373-1382.
Sadek, C.M., Jimenez, A., Damdimopoulos, A.E., Kieselbach, T., Nord, M., Gustafsson, J.-A., Spyrou, G., Davis, E.C., Oko, R., van der Hoorn, F.A., et al. 2003. Characterization of human thioredoxin-like 2. A novel microtubule-binding thioredoxin expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and axoneme. J. Biol. Chem. 278: 13133-13142.
Spyrou, G., Enmark, E., Miranda-Vizuete, A., and Gustafsson, J.-A. 1997. Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 272: 2936-2941.
Tanaka, T., Hosoi, F., Yamaguchi-Iwai, Y., Nakamura, H., Masutani, H., Ueda, S., Nishiyama, A., Takeda, S., Wada, H., Spyrou, G., et al. 2002. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 21: 1695-1703.
Wahl, M.C., Irmler, A., Hecker, B., Schrimer, R.H., and Becker, K. 2005. Comparative structural analysis of oxidized and reduced thioredoxin from Drosophila melanogaster. J. Mol. Biol. 345: 1119-1130.
Weichsel, A., Gasdaska, J.R., Powis, G., and Montfort, W.R. 1996. Crystal structures of reduced, oxidized, and mutated human thioredoxins: Evidence for regulatory homodimer. Structure 4: 735-751.
Wood, Z.A., Schröder, E., Harris, J.R., and Poole, L.B. 2003. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28: 32-40.
Zhang, R., Al-Lamki, R., Bai, L., Streb, J.W., Miano, J.M., Bradley, J., and Min, W. 2004. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ. Res. 94: 1438-1491.